Free Trial

Azenta (NASDAQ:AZTA) Reaches New 12-Month Low on Disappointing Earnings

Azenta logo with Medical background

Azenta, Inc. (NASDAQ:AZTA - Get Free Report) shares reached a new 52-week low on Wednesday following a weaker than expected earnings announcement. The company traded as low as $23.91 and last traded at $26.05, with a volume of 36697 shares changing hands. The stock had previously closed at $25.42.

The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. The business's revenue was up 5.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.06 EPS.

Analysts Set New Price Targets

A number of brokerages have issued reports on AZTA. Evercore ISI boosted their price target on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research note on Thursday, February 6th. Needham & Company LLC cut their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a research note on Wednesday, May 7th. Finally, TD Cowen upgraded shares of Azenta to a "hold" rating in a research note on Thursday, February 27th.

Get Our Latest Stock Report on Azenta

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of Azenta by 8.9% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,842 shares of the company's stock worth $168,000 after acquiring an additional 396 shares in the last quarter. Ballentine Partners LLC lifted its stake in Azenta by 2.0% in the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after buying an additional 404 shares in the last quarter. Boothbay Fund Management LLC raised its holdings in Azenta by 8.4% in the 4th quarter. Boothbay Fund Management LLC now owns 6,571 shares of the company's stock valued at $329,000 after acquiring an additional 509 shares during the last quarter. Picton Mahoney Asset Management raised its holdings in Azenta by 305.7% in the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after acquiring an additional 532 shares during the last quarter. Finally, KBC Group NV increased its holdings in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after buying an additional 698 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Trading Up 7.2%

The stock's fifty day moving average price is $31.45 and its 200-day moving average price is $42.03. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of -9.63 and a beta of 1.64.

Azenta Company Profile

(Get Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

See Also

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines